Skip to content
Commercial Litigation Woods Lonergan LLP

212.684.2500

Copyright Litigation

Neuralstem to Present at The Neuroscience Innovation Forum for BD&L and Investment in Therapeutics and Technology - GlobeNewswire (press release)

January 5, 2018 - 5:25pm

Neuralstem to Present at The Neuroscience Innovation Forum for BD&L and Investment in Therapeutics and Technology
GlobeNewswire (press release)
Specific risks and uncertainties that could cause our actual results to differ materially from those expressed in our forward-looking statements include risks inherent in the development and commercialization of potential products, uncertainty of ...

and more »

Alliqua BioMedical, Inc. Announces Definitive Asset Purchase Agreement with Celularity, Inc. - GlobeNewswire (press release)

January 5, 2018 - 4:30pm

Alliqua BioMedical, Inc. Announces Definitive Asset Purchase Agreement with Celularity, Inc.
GlobeNewswire (press release)
The asset purchase agreement includes all intellectual property and all license, marketing, development and supply agreements related to these businesses. The Company's contract manufacturing assets and operations are not included in the asset purchase ...

and more »

ReWalk Robotics Ltd. Appoints Ori Gon as Chief Financial Officer - GlobeNewswire (press release)

January 5, 2018 - 4:30pm

ReWalk Robotics Ltd. Appoints Ori Gon as Chief Financial Officer
GlobeNewswire (press release)
... and the Food and Drug Administration's potential regulatory developments with respect to, ReWalk's mandatory post-market 522 surveillance study; the outcome of ongoing shareholder class action litigation relating to ReWalk's initial public offering ...

and more »

Alpha and Omega Semiconductor to Present at the 20th Annual Needham Growth Conference - GlobeNewswire (press release)

January 5, 2018 - 4:05pm

Alpha and Omega Semiconductor to Present at the 20th Annual Needham Growth Conference
GlobeNewswire (press release)
AOS has developed extensive intellectual property and technical knowledge that encompasses the latest advancements in the power semiconductor industry, which enables us to introduce innovative products to address the increasingly complex power ...

and more »

FORM Holdings Announces Name Change to XpresSpa Group ... - GlobeNewswire (press release)

January 5, 2018 - 4:02pm

FORM Holdings Announces Name Change to XpresSpa Group ...
GlobeNewswire (press release)
NEW YORK, Jan. 05, 2018 (GLOBE NEWSWIRE) -- FORM Holdings Corp. (Nasdaq:FH), a diversified holding company, today announced that it has changed its corporate name to XpresSpa Group, Inc. The company will continue trading on Nasdaq, and will commence ...

and more »

HypGen Inc. to Present During Biotech Showcase 2018 - GlobeNewswire (press release)

January 5, 2018 - 9:45am

HypGen Inc. to Present During Biotech Showcase 2018
GlobeNewswire (press release)
... the Company's ability to successfully defend its intellectual property or obtain the necessary licenses at a cost acceptable to the Company, if at all; the successful implementation of the Company's research and development programs and ...

and more »

Pernix Announces Reorganization of Sales Force to Focus on Zohydro® ER with BeadTek™ and Silenor® - GlobeNewswire (press release)

January 5, 2018 - 8:31am

Pernix Announces Reorganization of Sales Force to Focus on Zohydro® ER with BeadTek™ and Silenor®
GlobeNewswire (press release)
“Zohydro ER is a critical component of our long-term growth strategy, as we possess a strong intellectual property portfolio around this product, which provides for a lengthy exclusivity period. As a result of the cost savings associated with this ...

and more »

Zafgen Reports Strong Clinical Progress and Updates Outlook for 2018 - GlobeNewswire (press release)

January 5, 2018 - 7:00am

Zafgen Reports Strong Clinical Progress and Updates Outlook for 2018
GlobeNewswire (press release)
BOSTON, Jan. 05, 2018 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel therapies for patients affected by a range of metabolic ...

and more »

Idera Pharmaceuticals Provides 2018 Update and Outlook - GlobeNewswire (press release)

January 5, 2018 - 7:00am

Idera Pharmaceuticals Provides 2018 Update and Outlook
GlobeNewswire (press release)
All statements, other than statements of historical fact, included or incorporated in this press release, including statements regarding the Company's strategy, future operations, collaborations, intellectual property, cash resources, financial ...

and more »

Blue Line Responds to US Attorney General Statement Regarding Cannabis Industry Enforcement - GlobeNewswire (press release)

January 5, 2018 - 7:00am

GlobeNewswire (press release)

Blue Line Responds to US Attorney General Statement Regarding Cannabis Industry Enforcement
GlobeNewswire (press release)
Denver, CO, Jan. 05, 2018 (GLOBE NEWSWIRE) -- Blue Line Protection Group, Inc. (OTCPink: BLPG) is reiterating its commitment to ensuring the legal cannabis industry operates in a safe, secure and compliant manner, in light of the recent memo issued by ...

and more »

Exclusive - Renault-Nissan sets up $200 million fund to tap startups: sources - Reuters UK

January 5, 2018 - 6:45am

Reuters UK

Exclusive - Renault-Nissan sets up $200 million fund to tap startups: sources
Reuters UK
To accelerate the process, many are investing directly in the new services - and gaining access to intellectual property - via their own corporate venture capital (CVC) funds. BMW (BMWG.DE) has purchased stakes in a plethora of ride-sharing, smart ...

and more »

Brookfield Business Partners to Acquire Controlling Interest in Schoeller Allibert in Partnership With Schoeller Group - GlobeNewswire (press release)

January 5, 2018 - 2:00am

Brookfield Business Partners to Acquire Controlling Interest in Schoeller Allibert in Partnership With Schoeller Group
GlobeNewswire (press release)
... and industrials company of Brookfield Asset Management Inc. (NYSE:BAM) (TSX:BAM.A) (EURONEXT:BAMA), a leading global alternative asset manager with over $265 billion of assets under management. For more information, please visit our website at ...

and more »

Veritas Pharma Provides Year End Update on Company's Activities ... - GlobeNewswire (press release)

January 4, 2018 - 5:24pm

Veritas Pharma Provides Year End Update on Company's Activities ...
GlobeNewswire (press release)
VANCOUVER, British Columbia, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to provide an update to its prospective and current Veritas Shareholders regarding the ...

and more »

K2M Group Holdings, Inc. to Present at the 36th Annual JP Morgan Healthcare Conference - GlobeNewswire (press release)

January 4, 2018 - 4:40pm

K2M Group Holdings, Inc. to Present at the 36th Annual JP Morgan Healthcare Conference
GlobeNewswire (press release)
... continuing worldwide economic instability; our ability to protect our intellectual property rights; patent litigation and product liability lawsuits; damages relating to trade secrets or non-competition or non-solicitation agreements; risks ...

and more »

Eloxx Pharmaceuticals Chairman and CEO Robert Ward to ... - GlobeNewswire (press release)

January 4, 2018 - 11:39am

Eloxx Pharmaceuticals Chairman and CEO Robert Ward to ...
GlobeNewswire (press release)
WALTHAM, Mass., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (“Eloxx”) (OTC:SVOND), a clinical-stage biopharmaceutical company developing novel small molecule medicines to treat rare and ultra-rare genetic diseases caused by nonsense ...

and more »

Auris Medical Provides Update on AM-111 Development Program - GlobeNewswire (press release)

January 4, 2018 - 8:31am

Auris Medical Provides Update on AM-111 Development Program
GlobeNewswire (press release)
These risks and uncertainties include, but are not limited to, Auris Medical's need for and ability to raise substantial additional funding to continue the development of its product candidates, the timing and conduct of clinical trials of Auris ...

Cascadian Therapeutics Announces 2018 Outlook and Recent ... - GlobeNewswire (press release)

January 4, 2018 - 8:31am

Cascadian Therapeutics Announces 2018 Outlook and Recent ...
GlobeNewswire (press release)
SEATTLE, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Cascadian Therapeutics, Inc. (NASDAQ:CASC), a clinical-stage biopharmaceutical company, today announced an overview of recent progress for tucatinib, an investigational oral, small molecule kinase inhibitor ...

and more »

Auris Medical Provides Update on AM-111 Development Program - GlobeNewswire (press release)

January 4, 2018 - 8:31am

Auris Medical Provides Update on AM-111 Development Program
GlobeNewswire (press release)
These risks and uncertainties include, but are not limited to, Auris Medical's need for and ability to raise substantial additional funding to continue the development of its product candidates, the timing and conduct of clinical trials of Auris ...

and more »

OraSure Technologies Announces Management Succession Plan - GlobeNewswire (press release)

January 4, 2018 - 6:00am

GlobeNewswire (press release)

OraSure Technologies Announces Management Succession Plan
GlobeNewswire (press release)
... uncertainty relating to patent protection and potential patent infringement claims; uncertainty and costs of litigation relating to patents and other intellectual property; availability of licenses to patents or other technology; ability to enter ...

and more »